Glycosaminoglycans (GAGs) are involved in the pathogenesis of several urologic chronic diseases. Thus, GAGs replenishment therapy is widely reported as a therapeutic tool for chronic pelvic pain (CPP) conditions such as interstitial cystitis/bladder pain syndrome (IC/BPS) and prostate pain syndrome/chronic prostatitis. In this article we reviewed the current status of evidence on the clinic applications of glycosaminoglycans (GAGs) in the CPP.
Iacovelli, V., Bianchi, D., Pletto, S., Pacini, P., Fede Spicchiale, C., Finazzi Agrò, E. (2020). The role of glycosaminoglycans in the management of chronic pelvic pain: a systematic review. MINERVA UROLOGICA E NEFROLOGICA, 72(3), 321-331 [10.23736/S0393-2249.20.03672-3].
The role of glycosaminoglycans in the management of chronic pelvic pain: a systematic review
Finazzi Agrò, EnricoWriting – Review & Editing
2020-01-01
Abstract
Glycosaminoglycans (GAGs) are involved in the pathogenesis of several urologic chronic diseases. Thus, GAGs replenishment therapy is widely reported as a therapeutic tool for chronic pelvic pain (CPP) conditions such as interstitial cystitis/bladder pain syndrome (IC/BPS) and prostate pain syndrome/chronic prostatitis. In this article we reviewed the current status of evidence on the clinic applications of glycosaminoglycans (GAGs) in the CPP.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
